Prescient Therapeutics Ltd. (ASX:PTX)
(Formerly Virax Holdings Limited)
Virax Holdings Limited was a publicly listed early-stage development biopharmaceutical company focused on the development of immuno- therapeutics for the treatment of autoimmune disorders, HIV/AIDS, cancers and infectious diseases. TSL was employed by Virax as its corporate advisor to conduct several capital raisings.
- Conducted a public capital raising of $2.8 million in late 1998
- Conducted a private placement of $4.19 million in July 2000
- Provided corporate advisory services, including assistance with prospectus preparation and related offer documentation, planning and coordination of road-show presentations to brokers and investors, and advice on issue price and timing
To learn more about Prescient Therapeutics Limited visit their web-site here.